Literature DB >> 679154

Plasma copper and zinc levels in patients with malignant tumors of digestive organs: clinical evaluation of the C1/Zn ratio.

S Inutsuka, S Araki.   

Abstract

The plasma copper level (PCL) and plasma zinc level (PZL) were determined in 126 patients: 54 had carcinomas of which 40 were carcinomas of the digestive organs, 37 had benign lesions, and 35 were without disease. The PCL increased and the PZL decreased significantly in the group with carcinoma of the digestive organs. The CuHZn ratio was not only significantly higher than in the normal group, but also was high in cases with advanced carcinoma especially when liver metastasis was present. Therefore, the Cu/Zn ratio may be valuable in estimating the extent of the carcinoma as well as in determining the prognosis of the cancer patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679154     DOI: 10.1002/1097-0142(197808)42:2<626::aid-cncr2820420232>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Authors:  Di Chen; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

2.  Zinc and copper accumulation and isometallothionein induction in mouse ascites sarcoma S180A cells.

Authors:  S Kobayashi; J Sayato-Suzuki
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

3.  Involvement of plasma copper, zinc and cadmium in human carcinoma of uterine cervix.

Authors:  N Balasubramaniyan; S Subramanian; N Sekar; V Bhuvarahamurthy; S Govindasamy
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy.

Authors:  H Y Hsu; S Y Lin; C J Huang; S L Lian; Y H Ho
Journal:  Biol Trace Elem Res       Date:  1994 Oct-Nov       Impact factor: 3.738

5.  Zinc and copper levels in plasma, erythrocytes, and whole blood in cancer patients.

Authors:  Y Aldor; N Walach; D Modai; Y Horn
Journal:  Klin Wochenschr       Date:  1982-04-01

6.  Synchrotron X-ray imaging reveals a correlation of tumor copper speciation with Clioquinol's anticancer activity.

Authors:  Raul A Barrea; Di Chen; Thomas C Irving; Q Ping Dou
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429

7.  Efficiency of serum copper/zinc ratio for differential diagnosis of patients with and without lung cancer.

Authors:  T Oyama; K Matsuno; T Kawamoto; T Mitsudomi; T Shirakusa; Y Kodama
Journal:  Biol Trace Elem Res       Date:  1994-08       Impact factor: 3.738

8.  Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer.

Authors:  I Yücel; F Arpaci; A Ozet; B Döner; T Karayilanoğlu; A Sayar; O Berk
Journal:  Biol Trace Elem Res       Date:  1994-01       Impact factor: 3.738

9.  Concentrations of some major and minor elements in larynx tissues with and without cancer.

Authors:  I Durak; M Kavutcu; O Canbolaţ; A U Işik; O Akyol
Journal:  Biometals       Date:  1994-01       Impact factor: 2.949

10.  Heavy and trace metals in carcinoma of the gallbladder.

Authors:  Somprakas Basu; Manish K Singh; Tej B Singh; Satyanam K Bhartiya; Sureshwar P Singh; Vijay K Shukla
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.